findmyKOL
Clinical trialNCT02234180TerminatedPhase 2Interventional

Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery

SponsorAcademic and Community Cancer Research UnitedEnrollment3Adenocarcinoma of the Gastroesophageal JunctionStage IIB Esophageal AdenocarcinomaStage IIIA Esophageal AdenocarcinomaStage IIIB Esophageal AdenocarcinomaStage IIIC Esophageal Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Carle Cancer Center

    Urbana, Illinois, United States

  • Cancer Center of Kansas - Wichita

    Wichita, Kansas, United States

  • Ochsner Medical Center Jefferson

    New Orleans, Louisiana, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Missouri Valley Cancer Consortium

    Omaha, Nebraska, United States

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Comprehensive Cancer Center of Wake Forest University

    Winston-Salem, North Carolina, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • Toledo Clinic Cancer Centers-Toledo

    Toledo, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2014
Primary completion
8 Jun 2016
Completion
8 Jun 2016
Last update posted
17 Oct 2018
Registered enrollment
3
Registry id
NCT02234180
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.